ストックスクリーナーアプリを入手
34.20
0.15%
0.0452
Immunovant Inc (IMVT) 最新ニュース
CrowdStrike To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
Nvidia, Astera Labs, Micron, Intel, United, Hasbro, Toll, Immunovant, Analog Devices, and More Movers - Barron's
IMVT rockets 35% despite wider loss as arthritis drug shines in study - MSN
Stifel Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $49 - Moomoo
Immunovant: Upgraded To 'Buy' Because Of IMVT-1402's Broad Potential (NASDAQ:IMVT) - Seeking Alpha
(IMVT) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
IMVT's Q4 loss wider than expected, stock up 35% on strong study data - MSN
Immunovant (IMVT) Is Up 24.2% After Axing Batoclimab To Back IMVT-1402 Autoimmune PivotHas The Bull Case Changed? - simplywall.st
symbol__ Stock Quote Price and Forecast - CNN
Immunovant COO Gloria Melanie sells $101,072 in company stock - Investing.com
Immunovant COO Gloria Melanie sells $101,072 in company stock By Investing.com - Investing.com South Africa
[Form 4] Immunovant, Inc. Insider Trading Activity - Stock Titan
Wells Fargo Sticks to Its Buy Rating for Immunovant (IMVT) - The Globe and Mail
These Analysts Increase Their Forecasts On Immunovant After Q4 Results - Sahm
BofA Securities Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $43 - Moomoo
Immunovant’s Talent Crunch: How Human Capital Risks Could Derail IMVT-1402 Development Across Six Indications - TipRanks
Immunovant (IMVT) Is Up 17.9% After Refocusing On IMVT-1402 Amid Wider LossesHas The Bull Case Changed? - Yahoo Finance
Immunovant director Atul Pande sells $192,000 in shares By Investing.com - Investing.com Nigeria
IMVT Maintains Buy Rating by B of A Securities -- Price Target R - GuruFocus
IMVT Maintains by HC Wainwright & Co. -- Price Target Raised to $40 - GuruFocus
Immunovant (IMVT) Stock Shot up after a Poor Quarterly Showing - FXLeaders
Roivant: Immunovant's Rheumatoid Arthritis Win Validates The Buy (NASDAQ:ROIV) - Seeking Alpha
LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $45 - Moomoo
IMVT's Q4 Loss Wider Than Expected, Stock Up 35% on Strong Study Data - The Globe and Mail
BofA raises Immunovant stock price target on higher peak sales outlook - Investing.com
A Quick Look at Today's Ratings for Immunovant(IMVT.US), With a Forecast Between $40 to $45 - Moomoo
Immunovant director Atul Pande sells $192,000 in shares - Investing.com India
Immunovant (IMVT) Hits 5-Year High on Stellar Arthritis Treatment Trial - Insider Monkey
Immunovant (IMVT) director exercises options, sells 6,000 shares under 10b5-1 plan - Stock Titan
Immunovant, Inc. Stock 12‑Month Price Target Raised to $43.67, Implies 66% Upside - TradingView
Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT - TechStock²
Roivant/Immunovant Find Success In Tough-To-Treat RA, Where J&J Failed - Citeline News & Insights
IMVT Stock Jumps As Traders Track Insider Ownership Filing - timothysykes.com
Immunovant rises on IMVT-1402 data in difficult-to-treat RA - BioWorld News
2 Biotech Stocks Are Surging Today Thanks to This Arthritis Drug - Barron's
[144] Immunovant, Inc. SEC Filing - Stock Titan
Immunovant Shares Just Surged 35% – Here’s Why - AskTraders
Immunovant stock hits 52-week high at 30.27 USD By Investing.com - Investing.com Australia
Immunovant, Inc. Stock 12‑Month Price Target Raised to $43.08, Implies 64% Upside - TradingView
Immunovant (IMVT) Stock Soars Over 20% Following Breakthrough Rheumatoid Arthritis Data - MEXC
Stifel reiterates Immunovant stock rating on trial results - Investing.com
Immunovant Stock Surges Despite Disappointing Earnings Miss - Benzinga
Stifel reiterates Immunovant stock rating on trial results By Investing.com - Investing.com Australia
Immunovant, Inc. Stock 12‑Month Price Target Raised to $42.55, Implies 62% Upside - TradingView
Crude Oil Down 5%; Lowe's Posts Upbeat EarningsImmunovant (NASDAQ:IMVT), Lowe's Companies (NYSE:LOW) - Benzinga
Immunovant (IMVT) Stock Surges 22% on Positive Rheumatoid Arthritis Trial Data - MEXC
These Stocks Are Today's Movers: Nvidia, Micron, Intel, United, Hasbro, Toll, Immunovant, Analog Devices, and More -- Barrons.com - Moomoo
2.25%
0.46%
大文字化:
|
ボリューム (24 時間):